Drugs & Targets European Commission approves second indication of Sarclisa for relapsed multiple myeloma April 23, 2021Vol.47 No.16
Drugs & Targets NeoGenomics establishes Biomarker Assist KRAS Single Gene Testing Program for advanced NSCLC April 23, 2021Vol.47 No.16
Drugs & Targets Trodelvy receives FDA accelerated approval for advanced urothelial cancer April 16, 2021Vol.47 No.15
Drugs & Targets GI Genius receives marketing authorization from FDA to detect potential signs of colon cancer April 16, 2021Vol.47 No.15
Drugs & Targets NCCN recognizes Oncotype DX test as the only multigene test to predict chemotherapy benefit in node-positive early-stage breast cancer April 09, 2021Vol.47 No.14
Drugs & Targets TriSalus Life Sciences, MD Anderson collaboration to evaluate treatment of solid tumors April 09, 2021Vol.47 No.14
Drugs & Targets Sarclisa in combination with carfilzomib, dexamethasone receives FDA approval for relapsed or refractory multiple myeloma April 02, 2021Vol.47 No.13
